HDAC6: A unique HDAC family member as a cancer target.

Kaur, Sumeet; Rajoria, Prerna; Chopra, Madhu

Kaur, Sumeet; Rajoria, Prerna; Chopra, Madhu.

Afiliação

Kaur S; Laboratory of Molecular Modeling and Anticancer Drug Development, Dr. B. R. Ambedkar Center for Biomedical Research, University of Delhi, Delhi, 110007, India.
Rajoria P; Laboratory of Molecular Modeling and Anticancer Drug Development, Dr. B. R. Ambedkar Center for Biomedical Research, University of Delhi, Delhi, 110007, India.
Chopra M; Laboratory of Molecular Modeling and Anticancer Drug Development, Dr. B. R. Ambedkar Center for Biomedical Research, University of Delhi, Delhi, 110007, India. mchopra@acbr.du.ac.in.

Cell Oncol (Dordr) ; 45(5): 779-829, 2022 Oct.

Article em En | MEDLINE | ID: mdl-36036883

Assuntos

Antineoplásicos; Neoplasias; Animais; Camundongos; Antineoplásicos/farmacologia; Desacetilase 6 de Histona/genética; Desacetilase 6 de Histona/metabolismo; Inibidores de Histona Desacetilases/farmacologia; Neoplasias/genética; Inibidores de Proteassoma

Palavras-chave

Cancer; Combination therapy; HDAC6; Signaling pathways; Tumorigenesis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias / Antineoplásicos Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google